Director, Biomarker Research Program; Professor, Institute of Academic Medicine; Professor, Weill Cornell Medical College,New York; Member, Houston Methodist Cancer Center; Visiting Professor, Department of Molecular & Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Dr. Marchetti is an international recognized expert and authority in the field of CTCs as clinically useful tools to combat cancer metastasis for improved patient outcome. With keen insights into the biology of brain metastasis, he pioneered models for discoveries of molecular determinants underlying brain metastasis and biomarker properties of brain-homing CTCs.
As a consummate scientist, Dr. Marchetti?s bibliography include 184 publications of which 79 are in peer-reviewed journals in the fields of neuroscience and oncology. He has received numerous awards and secured uninterrupted funding for 25 years by receiving grants from federal, state, institutional and private Agencies. He is a reviewer for the most prominent journals in cancer research and sits on editorial boards of ?Cancer Microenvironment, ?Tumor Viruses?, ?Vascular Cell?, "Clinical & Experimental Pathology", "International Journal of Oncology", ?Cancer Letters?, ?Journal of Cellular Biochemistry?, ?Discovery/Discovery Reports? (a journal from Harvard Medical School) and "Cancer Metastasis Reviews" among others. Dr. Marchetti is Editor-in-Chief of the ?Journal of Gene Therapy? and Editor of a Research Topic on CTCs in ?Frontiers Oncology?, and acts as Guest Editor of the International Journal of Molecular Sciences (Basel, Switzerland) on brain metastasis. Further, he served/serves on grant reviewing panels of the National Institutes of Health of USA and Italy, the Department of Defense of the United States, and is frequently invited as grant reviewer and consultant for multiple national and international Agencies and Companies devoted to oncology research
Tumor Viruses, Clinical & Experimental Pathology, Cancer Letters, Cellular Biochemistry, Gene Therapy, Oncology